ArticlePrecision radiation oncology2022
Patient-specific synthetic magnetic resonance imaging generation from cone beam computed tomography for image guidance in liver stereotactic body radiation therapy.
Article in Precision radiation oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 6 citations in OpenAlex.
- Real-time 3D synthetic MRI based on kV imaging for motion monitoring of abdominal radiotherapy in a conventional LINAC.Physics in medicine and biology · 2025Article
- Finite Element Method-Based Hybrid MRI/CBCT Generation to Improve Liver Stereotactic Body Radiation Therapy Targets Localization Accuracy.IEEE transactions on radiation and plasma medical sciences · 2025Article
- On-board synthetic 4D MRI generation from 4D CBCT for radiotherapy of abdominal tumors: A feasibility study.Medical physics · 2024Article
- Patient-specific deep learning for 3D protoacoustic image reconstruction and dose verification in proton therapy.Medical physics · 2024Article
- A review on 4D cone-beam CT (4D-CBCT) in radiation therapy: Technical advances and clinical applications.Medical physics · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 1 country.
Funding
Abstract
Objective: Despite its prevalence, cone beam computed tomography (CBCT) has poor soft-tissue contrast, making it challenging to localize liver tumors. We propose a patient-specific deep learning model to generate synthetic magnetic resonance imaging (MRI) from CBCT to improve tumor localization. Methods: A key innovation is using patient-specific CBCT-MRI image pairs to train a deep learning model to generate synthetic MRI from CBCT. Specifically, patient planning CT was deformably registered to prior MRI, and then used to simulate CBCT with simulated projections and Feldkamp, Davis, and Kress reconstruction. These CBCT-MRI images were augmented using translations and rotations to generate enough patient-specific training data. A U-Net-based deep learning model was developed and trained to generate synthetic MRI from CBCT in the liver, and then tested on a different CBCT dataset. Synthetic MRIs were quantitatively evaluated against ground-truth MRI. Results: The synthetic MRI demonstrated superb soft-tissue contrast with clear tumor visualization. On average, the synthetic MRI achieved 28.01, 0.025, and 0.929 for peak signal-to-noise ratio, mean square error, and structural similarity index, respectively, outperforming CBCT images. The model performance was consistent across all three patients tested. Conclusion: Our study demonstrated the feasibility of a patient-specific model to generate synthetic MRI from CBCT for liver tumor localization, opening up a potential to democratize MRI guidance in clinics with conventional LINACs.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.